Fingerprint
Dive into the research topics of 'Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Clive S. Zent, James B. Chen, Richard C. Kurten, Gur P. Kaushal, H. Marie Lacy, Steven A. Schichman
Research output: Contribution to journal › Article › peer-review